Warfarin and a Supplement Bag for Low Mood
A 74-year-old man with atrial fibrillation takes warfarin 5 mg daily; his INR has been stable at 2.4–2.8 for 8 months. He now reports 6 weeks of low mood, poor sleep, and reduced appetite after his wife moved to assisted living. He asks about St John's wort, fish oil, vitamin E, and ginkgo, all of which a friend recommended for mood and memory. He also takes metoprolol 50 mg twice daily and atorvastatin 40 mg nightly. He denies suicidal ideation, fever, focal weakness, and chest pain. BP 132/78 mmHg; HR 68 bpm and irregular. He has no history of bleeding, falls, or liver disease. He wants to avoid prescription antidepressants because of concerns about side effects and asks whether the supplements are safe with warfarin.
1. Which of the proposed supplements are unsafe with warfarin, and what is the mechanism?
Read the worked answer
All four are problematic, for different reasons. St John's wort induces CYP3A4 and P-glycoprotein, which can lower warfarin exposure and reduce INR, risking thromboembolism; it can also interact with future antidepressants and cause serotonin syndrome. Fish oil, vitamin E, and ginkgo all increase bleeding risk through antiplatelet or anticoagulant effects, and ginkgo may also alter platelet function. Combining them with warfarin raises the risk of bruising, gastrointestinal bleeding, and intracranial hemorrhage, especially in an older adult.
The patient's stable INR does not make these supplements safe. I would advise against all four, specifically explain the interaction mechanisms, and ask him to bring in any product he is already taking. I would also check a current INR because his mood change and reduced appetite could affect warfarin intake or vitamin K intake.
2. How would you manage his depression without destabilizing anticoagulation?
Read the worked answer
I would first assess severity and safety: suicidal ideation, hopelessness, psychosis, and ability to care for himself. He denies suicidal ideation, but I would ask directly and arrange close follow-up. I would look for reversible contributors such as hypothyroidism, anemia, B12 deficiency, pain, and sleep apnea, and order a CBC, TSH, B12, and metabolic panel as indicated. Psychotherapy, behavioral activation, grief support, and sleep hygiene are first-line and do not interact with warfarin.
If an antidepressant is needed, I would avoid St John's wort and choose an SSRI such as sertraline, starting low and coordinating with his prescriber. SSRIs can increase bleeding risk with warfarin, especially early, so I would monitor INR and symptoms of bleeding. I would not stop warfarin for depression treatment. The key is to treat the mood disorder with evidence-based care while keeping anticoagulation stable and monitored.